{
  "Q0": "Whole Genome Sequencing (WGS)",
  "Q1": "Yes",
  "Q2": "Not specified",
  "Q3": "No",
  "Q4": "Yes",
  "Q4a": "No",
  "Q4b": "None of the above",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8a": "No genetic test is appropriate per policy for this clinical scenario; targeted single-gene or panel testing is not indicated for isolated anxiety/behavioral issues without developmental delay or syndromic features.",
  "Q9": "Yes",
  "Q9a": "No",
  "Q10": "No",
  "Q10a": "Diagnostic",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14a": "81425 (Genome, sequence analysis)",
  "Q15": "No",
  "Q16": "No",
  "Q17": "The policy requires that all medical necessity criteria be met, including: (1) the patient must have unexplained congenital or neurodevelopmental disorder with a high likelihood of genetic etiology, (2) the result must impact clinical management, (3) prior evaluation by a board-certified/eligible medical geneticist, (4) pre- and post-test genetic counseling, (5) exclusion of alternative etiologies, (6) clinical presentation does not fit a well-described syndrome for which single-gene or targeted panel testing is available, and (7) WGS is more efficient than other tests. For this patient, these criteria are not met. Submit claim only if all criteria are documented and satisfied, including documentation of geneticist evaluation, counseling, and that the clinical scenario matches policy requirements.",
  "match": true
}